RPR 2: structure given in first source
ID Source | ID |
---|---|
PubMed CID | 6438560 |
MeSH ID | M0183251 |
Synonym |
---|
rpr 2 |
rpr-ii |
2-butenoic acid 3-(diethoxyphosphinothioyl)methyl ester |
rpr-2 |
rpr ii |
2-butenoic acid, 3-((diethoxyphosphinothioyl)oxy)-, methyl ester |
128606-48-4 |
57113-18-5 |
methyl 3-[(diethoxyphosphorothioyl)oxy]but-2-enoate |
DTXSID90858835 |
methyl (2e)-3-[(diethoxyphosphorothioyl)oxy]but-2-enoate |
3-[(diethoxyphosphinothioyl)oxy]-2-butenoic acid methyl ester |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (27.27) | 18.2507 |
2000's | 8 (72.73) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (38.06) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 12 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |